Product
GT20029
2 clinical trials
4 indications
Indication
Androgenetic AlopeciaIndication
Acne VulgarisIndication
AcneIndication
AlopeciaClinical trial
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose Escalation Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029 Following Topical Single and Multiple Ascending Dose AdministrationStatus: Completed, Estimated PCD: 2022-10-27
Clinical trial
A Randomized, Double-blind, Placebo-controlled Phase Ⅰ Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of GT20029 Gel and Solution for Single and Multi Dose External Administration in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-08-15